Dilution of Share Value from Stock Options
First written in FY2017. 6 of 16 entries say "Mitigated", first in FY2019. Latest entry: FY2026.
Crossfor moved to the "Worse" side of this theme in 2017, 4 years before the typical company in this theme (2021).
The whole theme swung hardest in 2017: 17 of 34 companies on the "Worse" side.
44 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「Decrease due to exercise of Series 6 stock acquisition rights 500,000」
During the fiscal year, stock acquisition rights covering 500,000 shares under Series 6 were exercised, resulting in an actual share issuance. As of the fiscal year-end, rights covering 1,642,800 shares remained unexercised, in addition to rights covering 5,000,000 shares under the convertible bond-type bonds with stock acquisition rights. - 2026-09-14WorsenedRevision of earnings forecasts
「普通株式増加数(株) － 3,091,013 (うち転換社債型新株予約権付社債(株)） － 2,849,315 (うち新株予約権(株)) － 241,698」
潜在株式調整後1株当たり当期純利益の算定上、転換社債型新株予約権付社債及び新株予約権による普通株式増加数が示され、希薄化エクスポージャーが確認された。 - FY2026-H1WorsenedAnnual report
「Class, details and number of shares underlying stock acquisition rights ※ Common shares 2,142,800 shares (Note 1)」
The company issued Series 6 stock acquisition rights covering 2,142,800 common shares to one VC. In addition, the Series 1 unsecured convertible bond-type bonds with stock acquisition rights cover 5,000,000 common shares, increasing the potential scale of dilution of shareholder value. - FY2025MitigatedAnnual report
「Remaining unexercised —」
Of the Series 4 stock acquisition rights, 40,000 shares were exercised and 12,000 shares expired, leaving none unexercised. The potential scale of dilution of shareholder value was eliminated. - FY2025-H1MaterialisedAnnual report
「The increase resulted from the exercise of stock options.」
During the interim accounting period, the total number of issued shares increased by 40,000, resulting in an actual share issuance through the exercise of stock acquisition rights. The company stated that there were no applicable new grants of stock acquisition rights or similar instruments. - FY2024MitigatedAnnual report
「Exercised 60,000 — Expired — 153,800 Remaining unexercised 52,000 —」
Of the Series 4 stock acquisition rights, 60,000 shares were exercised, leaving 52,000 unexercised, while all 153,800 Series 5 stock acquisition rights expired. The potential scale of dilution decreased. - FY2023MitigatedAnnual report
「Remaining unexercised 112,000 153,800」
The remaining unexercised stock acquisition rights were 112,000 shares for Series 4 and 153,800 shares for Series 5, with Series 5 down 200 shares from 154,000 in the previous fiscal year. - FY2022MitigatedAnnual report
「Expired — 1,000 Remaining unexercised 112,000 154,000」
Of the Series 5 stock acquisition rights, rights covering 1,000 shares expired, leaving 154,000 shares unexercised. The potential scale of dilution decreased slightly. - FY2021MitigatedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares under the stock option plan was 267,000, equivalent to 1.5% of the total 17,603,500 issued shares.」
Potential shares decreased slightly from 267,200 in the previous fiscal year to 267,000, while the ratio remained at 1.5%. - FY2020RestatedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares under the stock option plan was 267,200, equivalent to 1.5% of the total 17,522,000 issued shares.」
Potential shares decreased slightly from 268,200 in the previous fiscal year to 267,200, while the ratio remained at 1.5%. - FY2019MitigatedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares under the stock option plan was 268,200, equivalent to 1.5% of the total 17,522,000 issued shares.」
Potential shares decreased from 275,800 in the previous fiscal year to 268,200, while the ratio to total issued shares fell from 1.6% to 1.5%. - FY2019-Q2MaterialisedAnnual report
「Change in total issued shares 4,000 shares (Note) Increase due to the exercise of stock acquisition rights.」
Between 1 November 2018 and 31 January 2019, the exercise of stock acquisition rights increased the number of shares by 4,000, and the potential dilution of shareholder value additionally materialized as an actual share issuance. - FY2018WorsenedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares under the stock option plan was 275,800, equivalent to 1.6% of the total 17,518,000 issued shares.」
Potential shares totaled 275,800, and the ratio to total issued shares was 1.6%, indicating an increase in the potential scale of dilution from the 1.0% disclosed for the previous fiscal year. - FY2018-Q3MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The exercise of stock acquisition rights increased the number of issued shares by 52,000, and the potential dilution of shareholder value has materialized as an actual share issuance. - FY2018-Q1WorsenedAnnual report
「Number of stock acquisition rights 800」
As a material subsequent event, stock acquisition rights covering 80,000 shares were newly allocated, increasing the potential for future dilution of shareholder value. - FY2017First statedAnnual report
「As of the consolidated fiscal year-end, the number of potential shares under the stock option plan was 88,000, equivalent to 1.0% of the total 8,729,000 shares issued.」
The company continues the plan to improve the morale of directors and employees and attract talent, while identifying dilution from exercise and deterioration in stock supply and demand as risks.